121 related articles for article (PubMed ID: 25292419)
1. Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review.
Andrew P; Valiani S; MacIsaac J; Mithoowani H; Verma S
Breast Cancer Res Treat; 2014 Nov; 148(1):1-5. PubMed ID: 25292419
[TBL] [Abstract][Full Text] [Related]
2. [Delayed appearance of maculopapular eruptions induced by tamoxifen].
Descamps V; Bouscarat F; Boui M; Marck Y; Lebrun-Vignes B; Crickx B; Belaich S
Ann Dermatol Venereol; 1999 Oct; 126(10):716-7. PubMed ID: 10604012
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen in men: a review of adverse events.
Wibowo E; Pollock PA; Hollis N; Wassersug RJ
Andrology; 2016 Sep; 4(5):776-88. PubMed ID: 27152880
[TBL] [Abstract][Full Text] [Related]
4. Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases.
Fumal I; Danchin A; Cosserat F; Barbaud A; Schmutz JL
Dermatology; 2005; 210(3):251-2. PubMed ID: 15785062
[No Abstract] [Full Text] [Related]
5. Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.
Rohatgi N; Blau R; Lower EE
J Womens Health Gend Based Med; 2002 Apr; 11(3):291-301. PubMed ID: 11988138
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen, hot flashes and recurrence in breast cancer.
Mortimer JE; Flatt SW; Parker BA; Gold EB; Wasserman L; Natarajan L; Pierce JP;
Breast Cancer Res Treat; 2008 Apr; 108(3):421-6. PubMed ID: 17541741
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen-associated vasculitis in a breast cancer patient.
Candelaria M; Hurtado-Monroy R; Vargas-Viveros P; Carrillo-Muñnoz S; Duenas-Gonzalez A
World J Surg Oncol; 2007 Jan; 5():9. PubMed ID: 17244373
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
Toulis KA; Tzellos T; Kouvelas D; Goulis DG
Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
[TBL] [Abstract][Full Text] [Related]
10. Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.
Curtis MG
Drug Saf; 2001; 24(14):1039-53. PubMed ID: 11735660
[TBL] [Abstract][Full Text] [Related]
11. Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.
Matsuda T; Ly NTM; Kambe N; Nguyen CTH; Ueda-Hayakawa I; Son Y; Okamoto H
J Dermatol; 2018 Mar; 45(3):344-348. PubMed ID: 29239026
[TBL] [Abstract][Full Text] [Related]
12. Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer.
Pandya KJ; Thummala AR; Griggs JJ; Rosenblatt JD; Sahasrabudhe DM; Guttuso TJ; Morrow GR; Roscoe JA
Breast Cancer Res Treat; 2004 Jan; 83(1):87-9. PubMed ID: 14997058
[TBL] [Abstract][Full Text] [Related]
13. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
Lee WL; Cheng MH; Chao HT; Wang PH
Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579
[TBL] [Abstract][Full Text] [Related]
14. First report of tamoxifen-induced baboon syndrome.
Mofarrah R; Mofarrah R; Kränke B; Rahmani M; Jahani Amiri K; Ghasemi M; Jallab N; Ghobadiaski S; Rahmani N; Hashemi N
J Cosmet Dermatol; 2021 Aug; 20(8):2574-2578. PubMed ID: 33253493
[TBL] [Abstract][Full Text] [Related]
15. Selective estrogen-receptor modulators in 2001.
O'Regan RM; Gradishar WJ
Oncology (Williston Park); 2001 Sep; 15(9):1177-85, 1189-90; discussion 1190-4. PubMed ID: 11589065
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
Chattopadhyay C; Chakrabarti N
Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer and duration of tamoxifen.
Prescrire Int; 2015 Sep; 24(163):220. PubMed ID: 26417636
[TBL] [Abstract][Full Text] [Related]
18. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
Levine M; Moutquin JM; Walton R; Feightner J;
CMAJ; 2001 Jun; 164(12):1681-90. PubMed ID: 11450210
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
Georgopoulos NA; Adonakis GL; Fotopoulos A; Koika V; Spinos N; Saltamavros A; Keramopoulos A; Koukouras D; Decavalas G; Kourounis GS
Gynecol Endocrinol; 2006 Apr; 22(4):185-9. PubMed ID: 16723304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
